skip to content

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 
Read more at: Read this month’s Cancer in Sight blog:  Living with pancreatic cancer – a patient’s perspective

Read this month’s Cancer in Sight blog:  Living with pancreatic cancer – a patient’s perspective

30 November 2022

This month’s Cancer in Sight blogs is by Sally, a patient and public involvement (PPI) member of the Cambridge Pancreatic Cancer Centre who was diagnosed with pancreatic cancer in 2011 . The Cancer in Sight series of blogs brings a range of perspectives to discuss issues around the IRC’s programme to develop new...


Read more at: IRC Investigator secures Medical Research Council (MRC) Confidence in Concept Award

IRC Investigator secures Medical Research Council (MRC) Confidence in Concept Award

10 November 2022

Professor Oren Scherman has received an MRC Confidence in Concept (CiC) award aimed at acceleration of the translational pathway of a promising invention. The CiC award has been granted to Prof Scherman, Director of the Melville Laboratory and Professor of Supramolecular and Polymer Chemistry in the Yusuf Hamied Department...


Read more at: IRC team at Meet the Researchers public event

IRC team at Meet the Researchers public event

4 November 2022

Members of the IRC team took part in a June Hancock Mesothelioma Research Fund Meet the Researchers event that brought together mesothelioma patients and their families with IRC researchers and clinicians. Meet the Researchers events are an opportunity for researchers and academics to engage with patients and practitioners...


Read more at: Read this month’s Cancer in Sight blog –  Targeted delivery: taking a multidisciplinary approach towards a shared goal

Read this month’s Cancer in Sight blog –  Targeted delivery: taking a multidisciplinary approach towards a shared goal

31 October 2022

The latest in our monthly series of Cancer in Sight blogs is by IRC Programme Manager Claire McGlynn who considers the benefits of bringing together a multidisciplinary team and future prospects for the programme This month’s blog titled ‘ Targeted delivery – taking a multidisciplinary approach towards a shared goal’...


Read more at: Read latest Cancer in Sight blog on the future promise of MOFs

Read latest Cancer in Sight blog on the future promise of MOFs

6 October 2022

The just-published Cancer in Sight blog, written by Professor David Fairén-Jiménez, lead of the Adsorption and Advanced Materials Lab at the University of Cambridge and IRC Investigator, sets out the future promise of MOFs to target hard-to-treat cancers. Explaining how his research is positioned in the wider IRC programme...


Read more at: Listen to IRC Investigators in conversation on Connect: Health Tech podcast

Listen to IRC Investigators in conversation on Connect: Health Tech podcast

4 October 2022

The hour-long podcast shines a light on the interdisciplinary structure of the IRC programme that spans five founding universities and brings together clinicians, scientists and engineers to develop novel technologies to target three hard-to-treat cancers – glioblastoma, pancreatic cancer and mesothelioma. The newly...


Read more at: IRC hosts seminar on local therapeutic delivery in brain cancer

IRC hosts seminar on local therapeutic delivery in brain cancer

23 September 2022

The IRC welcomed Ryan Mathew, Associate Professor, University of Leeds, Honorary Consultant Neurosurgeon, Leeds Teaching Hospitals NHS Trust f or the second in a series of interdisciplinary seminars. The sound of the Boomtown Rats singing ‘I don’t like Mondays’ marked the start of the seminar, now available to view on the...


Read more at: IRC researcher highlights potential of metal organic frameworks at UK Porous Materials Conference

IRC researcher highlights potential of metal organic frameworks at UK Porous Materials Conference

22 September 2022

Research Associate at the School of Chemistry, University of Glasgow, and member of the IRC team, Dr Arvin Eskandari , presented a talk about his current research into the drug delivery potential of metal organic frameworks (MOFs) for cancer therapy at the annual meeting of the Royal Society of Chemistry's Porous Materials...


Read more at: Taking a multidisciplinary approach to better target mesothelioma

Taking a multidisciplinary approach to better target mesothelioma

26 July 2022

This month’s Cancer in Sight blog is written by the IRC’s Professor Stefan Marciniak who explains why targeted delivery could be transformative for mesothelioma patients. As Professor of Respiratory Science and a Consultant in Respiratory Medicine at Addenbrooke's Hospital and the Royal Papworth Hospital, Cambridge...


Read more at: IRC hosts seminar on engineered therapeutics to reprogramme the tumour microenvironment

IRC hosts seminar on engineered therapeutics to reprogramme the tumour microenvironment

30 June 2022

The IRC welcomed Professor Dr Jai Prakash, Professor and Chair Engineered Therapeutics, at the Department of Advanced Organ Bioengineering and Therapeutics, TechMed Centre, University of Twente in the Netherlands for an interdisciplinary seminars. Professor Prakash started the seminar by bringing focus to the cellular and...